Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin GB0009252882
Ticker GSK.L
Company GLAXOSMITHKLINE
Currency £
Price
Aware Investor Index (AII) 290.7452
Recommendation STRONG BUY
P/E 44.99
ROE 100.00 %
Capitalization 293,410,164,996 $
Dividend Yield 2.09 %
P/S 9.76
AII Position 14
P/E Position 570
ROE Position 28
Capitalization Position 16
Dividend Yield Position 308
Sales 23,923,000,000 £
10-Year Average Earnings 5,192,400,000 £
Shares Outstanding 4,888,000,000
Equity 5,114,000,000 £
Dividend per Share 1 £
Industry Pharmaceutical
Country Great Britain
GLAXOSMITHKLINE Investor Relations Web Site http://www.gsk.com/investors.html







Sales:

YEAR MONTH AMOUNT
2015 12 23,923,000,000.00 £
2014 12 23,006,000,000.00 £
2013 12 26,505,000,000.00 £

Earnings:

YEAR MONTH AMOUNT
2015 12 8,422,000,000.00 £
2014 12 2,756,000,000.00 £
2013 12 5,436,000,000.00 £
2012 12 4,499,000,000.00 £
2011 12 5,208,000,000.00 £
2010 12 2,961,000,000.00 £
2009 12 6,283,000,000.00 £
2008 12 5,551,000,000.00 £
2007 12 5,310,000,000.00 £
2006 12 5,498,000,000.00 £

Equity:

YEAR MONTH AMOUNT
2015 12 5,114,000,000.00 £
2014 12 4,263,000,000.00 £
2013 12 7,812,000,000.00 £
2012 12 6,747,000,000.00 £
2011 12 8,827,000,000.00 £
2010 12 9,745,000,000.00 £
2009 12 10,742,000,000.00 £
2008 12 8,318,000,000.00 £
2007 12 9,910,000,000.00 £
2006 12 9,648,000,000.00 £

Shares Outstanding:

YEAR MONTH AMOUNT
2015 12 4,888,000,000
2014 12 4,865,000,000
2013 12 4,919,000,000
2012 12 4,913,000,000
2011 12 5,099,000,000
2010 12 5,128,000,000
2009 12 5,108,000,000
2008 12 5,226,000,000
2007 12 5,567,000,000
2006 12 5,700,000,000

 












Bloomberg News for GLAXOSMITHKLINE:

Apr 25, 2018
GlaxoSmithKline Earnings: Fixing Pharma on a Budget
GlaxoSmithKline PLC’s pharma revitalization is still pending. GSK claims fixing its teetering drug unit is a top priority, and its recent hire of Roche Holding AG vet Hal Barron to revamp R&D was...
Apr 19, 2018
Procter & Gamble Gobbles Up a Growth Supplement Pill
larger equivalent, which produces Advil painkillers. Both Reckitt Benckiser Plc and GlaxoSmithKline Plc have passed on the chance to pay as much as $20 billion for the unit.Against that backdrop...
Mar 27, 2018
Novartis to Sell Stake in Joint Venture to Glaxo for $13 Billion
GlaxoSmithKline Plc, the U.K. pharmaceutical giant, agreed to buy Novartis AG’s stake in its consumer healthcare joint venture in a $13 billion deal a week after withdrawing from the bidding for...
Mar 27, 2018
Unicorns Take Different Paths to Being Public
Group Board Seat, Avoiding Proxy Fight. Brookfield Strikes Deal to Buy Rest of Mall Owner GGP. GSK Gets Full Control of Sensodyne Maker for $13 Billion. How a Tiny Latvian Bank Became a Haven for...
Mar 6, 2018
Tiny U.K. Biotech Takes On Glaxo’s $730,000 Gene Therapy
GlaxoSmithKline Plc has seen precious few takers for its $730,000 gene therapy for a rare and life-threatening immune illness known as “bubble-boy disease.” Now a tiny startup thinks it can succeed...
Feb 28, 2018
Scientists Want to Completely Rethink How They Make the Flu Vaccine
ahead. Leading the charge from Big Pharma are drugmaking giants, including GlaxoSmithKline PLC, Sanofi SA and Johnson & Johnson.Sanofi, the world’s biggest flu-vaccine maker, signed a deal with SK...
Jul 3, 2012
UCITS-Depositary Rules, Glaxo’s $3 Billion, Libor: Compliance
Section: Libor Probe Diamond Defies Pressure to Quit, Pledging to Complete Review Barclays Plc Chief Executive Officer Robert Diamond defied pressure to quit after the bank was fined for rigging...
May 31, 2012
Human Genome Sciences Takeover Defense Survives Court Test
defense designed to fend off a $2.6 billion hostile buyout bid by drugmaker GlaxoSmithKline Plc. After a morning hearing, Montgomery County Circuit Court Judge Michael Mason in Rockville, Maryland...
Jul 16, 2012
Glaxo to Pay $3 Billion for Human Genome
GlaxoSmithKline Plc agreed to buy Human Genome Sciences Inc. for $3 billion in cash, winning control of its U.S. partner on the Benlysta lupus therapy after a three-month takeover battle and two...
Dec 13, 2012
Nobel Prize Winner Nurse Builds Lab to Culture U.K. Scientists
160-foot crane overhead. Temperature control is a critical detail for main contractor Laing O’Rourke Plc. If power were lost, researchers could lose years of frozen specimens and fragile material. ...


Google News for GLAXOSMITHKLINE:

Monroe Reporter - 4 hours ago
Glaxosmithkline Plc (GSK.L) Shares Run 0.79% For the Week
Shares of Glaxosmithkline Plc (GSK.L) have been trending up over the past five bars, revealing solid bullish momentum for the shares, as they ...
Derby Journal - 2 days ago
Glaxosmithkline Plc (GSK.L) Outperformed 27% of Peers This Year
Sell-side analysts covering shares of Glaxosmithkline Plc (GSK.L) have given a one year price objective of 1540.22. Compared to peers in the ...
euronews - 18 May 2018
EU warns of possible birth defect link to GSK's HIV drug
LONDON (Reuters) – Europe's medicines regulator said it was assessing evidence that GlaxoSmithKline's <GSK.L> successful HIV drug ...
Reuters - 17 May 2018
GSK bets on lift from new lung drugs ahead of Advair's last gasp
LONDON (Reuters) - GlaxoSmithKline (GSK.L) is putting more marketing muscle behind its new lung drugs and is looking for a sales boost as ...
Concordia Review - 1 day ago
Chartists Place Glaxosmithkline Plc (GSK.L) on Notice: Technical ...
Glaxosmithkline Plc (GSK.L)'s MACD Histogram reading is currently below the zero line, indicating a neutral or negative chart trend for the ...
Reuters - 9 May 2018
Drugmaker GSK rings in more change as CFO heads for exit in 2019
LONDON (Reuters) - GlaxoSmithKline Plc (GSK.L), Britain's biggest drugmaker, faces more top management change with Chief Financial ...
Concordia Review - 16 hours ago
Wilder Moving Average Seen Below the Simple Moving Average for ...
Zooming in on the numbers for Glaxosmithkline Plc (GSK.L), we have spotted the 21 day Wilder Moving Average below the 50 day SMA.
Danvers Record - 4 days ago
Fizzle or Sizzle? What's Behind the Numbers For Glaxosmithkline ...
The Average True Range of ATR For Shares of Glaxosmithkline Plc (GSK.L) have trended downward over the past 10 bars, indicating bearish ...
Investomania (blog) - 2 days ago
Are rising dividends ahead for BP plc, Vodafone Group plc ...
GlaxoSmithKline's 5%+ dividend yield appeals to me at the moment. I feel that the company has an improving financial outlook, with its decision ...
Park City Caller - 3 days ago
Investors Are Circling Glaxosmithkline Plc (GSK.L), What Do the ...
Glaxosmithkline Plc (GSK.L) shares are on close watch heading into the middle of the week as the price has moved below the Balance Step ...


Back